Engility subsidiary wins prime position on $900 million IDIQ to provide medical product research and development for the US Army and other Defense Department entities
Engility Holdings, Inc. (NYSE: EGL ), today announced that TASC, Inc., an Engility company, has won a prime position on a $900 million indefinite delivery/indefinite quantity (IDIQ) contract to provide professional and technical services supporting medical product research and development (MPRD) for the U.S. Army and other Department of Defense (DOD) entities. The contract, which represents new work, was awarded by the U.S. Army Medical Research and Materiel Command.
The MPRD program provides a mechanism for all aspects of medical product research and development and life cycle support to sustain this nation's warfighters. Work performed through task order contracts will include technical/administrative services; meeting and informational products; clinical and non-clinical development; medical product manufacturing; regulatory; training protocol and information technology.
Analysis of Exoskeleton Technology Implementation in Future Factories
"Engility appreciates the opportunity to provide unique technical support and innovative thought on this vital medical product research and development program, which ensures the servicemen and women who defend our country have the best medical supplies and medical assistance available," said Engility President and CEO Tony Smeraglinolo . "The MPRD contract is a very meaningful award and is projected to be a vehicle that is used throughout DOD for medical product research and development and support."
This IDIQ has a five-year base period of performance plus five one-year options, with a total contract value of $900 million for all awardees, if all options are exercised.
Source : Engility Holdings, Inc. - view original press release
May 15 - 16, 2017 - Prague, Czech Republic